Latest Breaking News On - Teena thacker - Page 1 : vimarsana.com

anti-obesity drugs: 'Obese people should opt for a structured programme of diet, exercise & medication'

"Nothing comes without a downside. These molecules do produce significant nausea and vomiting in some people — to the extent that they have to discontinue the medication. Some may develop diarrhoea, some may have severe constipation. Others may not like the way they lose weight—they may feel very shrunken or their face may seem very thinned out. Thats another sort of downside," says Dr Ambrish Mithal, chairman, endocrinology & diabetes, Max Healthcare, Delhi.

There can't be shortage of Polio vaccine; Serum Institute can make it: CEO Adar Poonawalla

Pune-based Serum Institute of India (SII) is prepared to increase production of injectable poliomyelitis vaccine (IPV) to fill the gap left by France's Sanofi closing its manufacturing plants in India. SII currently supplies half of the 20 million IPV doses to the government's immunization program and can provide additional doses with a 3-4 month notice. Adar Poonawalla, SII CEO, stated that supplying IPV to the government at current prices is unviable for most companies, but SII continues to do so as a service to the nation.

Eli Lilly: Weight-loss drug may be launched in India next year, says Eli Lilly CEO David Ricks

US drug maker Eli Lilly plans to launch its weight-loss drugs Zepbound and Mounjaro in India next year. The company is considering pricing based on supply and volume expansion. Eli Lilly CEO David Ricks suggests focusing on digital services in the Indian healthcare industry to encourage innovation and improve access to healthcare.

'Weight-loss Drug may be Launched in India Next Year'

At a market cap that exceeds $720 billion, US drug maker Eli Lilly tops the list of worlds most valuable pharmaceutical companies. The key to that is recent US approval for its weight-loss drug Zepbound (tirzepatide).

Morning Brief Podcast: Teens and mental health in India | The Economic Times Podcast

India's young adults are breaking taboos by seeking help for depression, anxiety, and stress. This is a positive step, but the surge in antidepressant use and "cool" mental health merch raises questions. Are we normalizing panic attacks? What's driving this surge in mental health issues? Academic pressure, social media, or deeper societal issues? Even students as young as 7 are battling depression and anxiety. What are schools doing about this? Host Ratna Bhushan talks to Geetika Kapoor, School Psychologist and founder of EdEssential, Ayesha Syal, Senior Faculty and Lead Educator, St Xaviers School, along with ET’s in-house expert Teena Thacker. Listen to the latest episode of The Morning Brief podcast! Credit: Abhi and Niyu, ABC News (Australia) and Indiatimes.

Philips to invest Rs 300 crore, hire 1,500 people in India, says global CEO Frans Van Houten

Faceoff: Netizens furious after Centre says 'no deaths due to lack of oxygen' | India News

Delta has not gone; worried about intensified second wave in rural India: IGIB chief

The second wave of the pandemic has just moved out of the big cities, but the intensified spread of Covid-19 in rural India is a bigger concern now than a possible third wave, says Anurag Agrawal, director of the Institute of Genomics and Integrative Biology (IGIB).

Morning Brief: The kids are alright: Why third Covid wave may not affect children more

Morning Brief (ET Bureau) Indulekha Aravind | 33:08 Min | June 03, 2021, 8:00 AM IST Parents are anxious and states are ramping up facilities but is there any actual evidence that a third wave might affect children disproportionately? Dr. Chandrakant Lahariya, epidemiologist and public health expert, Dr. Rakshay Shetty, head, pediatric intensive care, Rainbow Children's Hospital, and ET's Teena Thacker ease your worries. Credits: Audio clips from ABP News Hindi, NDTV, The Atlantic, The Economic Times, IndiaTV, DD News. Tags

sputnik v vaccine: Sputnik V will be subject to price controls: Government officials